Paysign Inc (PAYS)
Official siteTECHNOLOGY • SOFTWARE - INFRASTRUCTURE • NASDAQ
Market Cap: $541.25M
Last updated: Nov 17, 2026 at 11:06 AM ET
Paysign Inc (PAYS) Earnings: Report Dates and Results
Paysign (PAYS) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, Paysign reported EPS of $0.11, above the $0.10 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
PAYS has an expected report date of Mar 22, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 250.0% above the $0.02 reported for the quarter ended Dec 31, 2025.
PAYS Earnings Call
The latest PAYS earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 32 quarters below that had an estimate, PAYS beat 13, missed 12 and matched 7. Revenue for the quarter ended Sep 30, 2026 was $30.80M, up 42.6% from $21.60M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.11 | $0.10 | N/A | +10.00% | Beat | +175.0% | 2 | 2 up, 0 down | Nov 9, 2026 | $30.80M |
| Jun 30, 2026 | $0.11 | $0.14 | N/A | -21.43% | Miss | +450.0% | 3 | 1 up, 1 down | Aug 5, 2026 | $28.25M |
| Mar 31, 2026 | $0.09 | $0.03 | N/A | +197.00% | Beat | +78.2% | 4 | 3 up, 0 down | May 12, 2026 | $28.04M |
| Dec 31, 2025 | $0.02 | $0.03 | $0.02 - $0.04 | -33.33% | Miss | -19.0% | 4 | 0 up, 1 down | Mar 24, 2026 | $22.76M |
| Sep 30, 2025 | $0.04 | $0.04 | $0.02 - $0.05 | 0.00% | In line | +33.3% | 2 | 1 up, 1 down | Nov 12, 2025 | $21.60M |
| Jun 30, 2025 | $0.02 | $0.04 | $0.04 - $0.04 | -50.00% | Miss | +100.0% | 2 | 2 up, 0 down | Aug 5, 2025 | $19.08M |
| Mar 31, 2025 | $0.05 | $0.04 | $0.03 - $0.05 | +25.00% | Beat | +400.0% | 3 | 2 up, 0 down | May 8, 2025 | $18.60M |
| Dec 31, 2024 | $0.02 | $0.03 | N/A | -7.49% | Miss | -17.7% | 3 | 1 up, 0 down | Mar 25, 2025 | $15.61M |
| Sep 30, 2024 | $0.03 | $0.02 | N/A | +50.00% | Beat | +50.0% | 3 | 0 up, 0 down | Nov 5, 2024 | $15.26M |
| Jun 30, 2024 | $0.01 | $0.01 | $0.01 - $0.03 | 0.00% | In line | N/A | 3 | 0 up, 0 down | Jul 31, 2024 | $14.33M |
| Mar 31, 2024 | $0.01 | $0.01 | N/A | 0.00% | In line | N/A | 3 | 0 up, 0 down | May 7, 2024 | $13.19M |
| Dec 31, 2023 | $0.03 | $0.02 | $0.01 - $0.03 | +50.00% | Beat | +200.0% | 3 | 0 up, 0 down | Mar 26, 2024 | $13.69M |
| Sep 30, 2023 | $0.02 | $0.01 | $0.01 - $0.02 | +100.00% | Beat | 0.0% | 3 | 0 up, 0 down | Nov 7, 2023 | $12.40M |
| Jun 30, 2023 | $0.00 | $0.01 | N/A | -120.00% | Miss | N/A | 3 | 0 up, 0 down | Aug 8, 2023 | $11.04M |
| Mar 31, 2023 | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | May 10, 2023 | $10.14M |
| Dec 31, 2022 | $0.01 | $0.01 | $0.01 - $0.01 | 0.00% | In line | +400.0% | 3 | 0 up, 0 down | Mar 21, 2023 | $10.62M |
| Sep 30, 2022 | $0.02 | $0.02 | N/A | 0.00% | In line | N/A | 3 | 0 up, 0 down | Nov 8, 2022 | $10.60M |
| Jun 30, 2022 | $0.00 | -$0.01 | -$0.01 - $0.00 | +56.00% | Beat | N/A | 4 | 0 up, 0 down | Aug 9, 2022 | $8.60M |
| Mar 31, 2022 | -$0.01 | $0.01 | $0.00 - $0.01 | -200.00% | Miss | N/A | 4 | 0 up, 0 down | May 11, 2022 | $8.22M |
| Dec 31, 2021 | $0.00 | $0.01 | N/A | -83.33% | Miss | -80.0% | 4 | N/A | Mar 22, 2022 | $8.77M |
| Sep 30, 2021 | -$0.01 | -$0.01 | N/A | +20.00% | Beat | N/A | 3 | N/A | Nov 9, 2021 | $7.77M |
| Jun 30, 2021 | -$0.02 | -$0.01 | -$0.01 - $0.00 | -100.00% | Miss | -300.0% | 3 | N/A | Aug 10, 2021 | $6.65M |
| Mar 31, 2021 | -$0.03 | $0.02 | $0.01 - $0.02 | -250.00% | Miss | -160.0% | 3 | N/A | May 11, 2021 | $6.28M |
| Dec 31, 2020 | $0.01 | $0.01 | -$0.01 - $0.04 | 0.00% | In line | -80.0% | 4 | N/A | Mar 25, 2021 | $7.25M |
| Sep 30, 2020 | -$0.14 | $0.02 | $0.00 - $0.03 | -800.00% | Miss | -333.3% | 4 | N/A | Nov 17, 2020 | N/A |
| Jun 30, 2020 | $0.01 | $0.03 | $0.02 - $0.06 | -66.67% | Miss | -80.0% | 4 | N/A | Aug 13, 2020 | $6.44M |
| Mar 31, 2020 | $0.05 | $0.04 | $0.03 - $0.05 | +25.00% | Beat | +66.7% | 4 | N/A | May 7, 2020 | $10.58M |
| Dec 31, 2019 | $0.05 | $0.06 | $0.05 - $0.07 | -16.67% | Miss | +150.0% | 5 | N/A | Dec 31, 2019 | $9.76M |
| Sep 30, 2019 | $0.06 | $0.04 | $0.03 - $0.05 | +50.00% | Beat | +140.0% | 3 | N/A | Nov 5, 2019 | $9.01M |
| Jun 30, 2019 | $0.05 | $0.03 | $0.02 - $0.05 | +66.67% | Beat | +150.0% | 4 | N/A | Aug 6, 2019 | $8.64M |
| Mar 31, 2019 | $0.03 | $0.02 | $0.02 - $0.03 | +50.00% | Beat | +200.0% | 2 | N/A | May 7, 2019 | $7.26M |
| Dec 31, 2018 | $0.02 | $0.02 | $0.02 - $0.02 | 0.00% | In line | +100.0% | 2 | N/A | Mar 11, 2019 | $6.87M |
| Sep 30, 2018 | $0.03 | $0.02 | N/A | +25.00% | Beat | +150.0% | N/A | N/A | Nov 13, 2018 | $6.42M |
| Jun 30, 2018 | $0.02 | N/A | N/A | N/A | N/A | +100.0% | N/A | N/A | Aug 9, 2018 | $5.46M |
| Mar 31, 2018 | $0.01 | N/A | N/A | N/A | N/A | 0.0% | N/A | N/A | May 14, 2018 | $4.68M |
| Dec 31, 2017 | $0.01 | N/A | N/A | N/A | N/A | -14.5% | N/A | N/A | Mar 26, 2018 | $4.61M |
| Sep 30, 2017 | $0.01 | N/A | N/A | N/A | N/A | -9.9% | N/A | N/A | Nov 13, 2017 | $4.00M |
| Jun 30, 2017 | $0.01 | N/A | N/A | N/A | N/A | +28.2% | N/A | N/A | Aug 10, 2017 | $3.42M |
| Mar 31, 2017 | $0.01 | N/A | N/A | N/A | N/A | +426.3% | N/A | N/A | May 15, 2017 | $3.20M |
| Dec 31, 2016 | $0.01 | N/A | N/A | N/A | N/A | +631.2% | N/A | N/A | Mar 27, 2017 | $3.05M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.13, up 74.0% from the year before. It was $0.03 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.13 | +74.0% |
| Dec 31, 2024 | $0.07 | N/A |
| Dec 31, 2023 | $0.04 | N/A |
| Dec 31, 2022 | $0.02 | N/A |
| Dec 31, 2021 | -$0.06 | N/A |
| Dec 31, 2020 | -$0.07 | -136.8% |
| Dec 31, 2019 | $0.19 | +153.3% |
| Dec 31, 2018 | $0.08 | N/A |
| Dec 31, 2017 | $0.04 | N/A |
| Dec 31, 2016 | $0.03 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,200 words across 7 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,223 | 7 | |
| 2026Q1 | Mar 31, 2026 | 4,282 | 8 | |
| 2025Q4 | Dec 31, 2025 | 5,409 | 7 | |
| 2025Q3 | Sep 30, 2025 | 3,735 | 7 | |
| 2025Q2 | Jun 30, 2025 | 3,968 | 7 | |
| 2025Q1 | Mar 31, 2025 | 1,994 | 3 | |
| 2024Q4 | Dec 31, 2024 | 4,489 | 8 | |
| 2024Q3 | Sep 30, 2024 | 4,228 | 7 |
2026Q3 Earnings Call
Opening remarks
Mark Newcomer President and CEO Thank you, Diego, and good afternoon, everyone. Thank you for joining us for Paysign's Third Quarter 2026 Earnings Call. I'm Mark Newcomer, President and Chief Executive Officer. I'm joined today by Jeff Baker, our Chief Financial Officer. Also with us on the call is Matt Turner, our President of Patient Affordability, and Matt Lanford, our Chief Payments Officer, both of whom will be available for Q&A following our prepared remarks. Earlier today, we reported our third-quarter results, delivering record revenue, operating income and adjusted EBITDA. To recap the quarter, revenue grew 43% year-over-year to $30.8 million. Net income grew over 200% to $6.7 million, or $0.11 per fully diluted share. Gross margins expanded 840 basis points to 64.7%, as patient affordability became a larger share of our revenue mix, growing 110% year-over-year. We expect gross and operating margins to continue to expand as patient affordability becomes a greater part of our revenue mix. Before I get into the details, I want to put this quarter in context within the broader strategy we've been executing against. As you know, Paysign has historically been known as a payment processor primarily serving the plasma industry. We built a leading position in that business, and it remains a good one, but it is a mature market with limited growth, and the nature of payment processing is transactional. We wanted to add business lines with real growth and a more durable value proposition that leverages our existing infrastructure. Patient affordability was that first complement. Our products and services deliver measurable value to our pharmaceutical clients by helping them increase sales and save money. Importantly, it helps patients start and stay on the treatments they need but might not otherwise be able to afford. That combination of value for the manufacturer and an outcome for the patient is what makes these relationships sticky. It also carries more attractive margins. Pairing the two gives us a better model, with a cash-generative plasma business alongside a fast-growing, higher-margin business with a large and growing market. The strategy is working. You can see it in the growth, the margin expansion and the operating leverage we delivered this quarter, and we believe it is creating real value for our shareholders. Within that context, I want to cover the plasma customer update in our release. One of our customers has informed us that it will be moving the payment processing for 113 centers to another provider, with the transition expected to be completed in the fourth quarter. As we understand it, the customer is consolidating this business with an existing banking partner with whom it has a broader relationship.
Frequently Asked Questions About PAYS
When is Paysign's next earnings date?
Paysign's next earnings report is expected for Mar 22, 2027.
Did PAYS beat earnings estimates last quarter?
Yes. Paysign reported EPS of $0.11 for the quarter ended Sep 30, 2026, above the $0.10 estimate, a 10.00% surprise.
What EPS do analysts expect from PAYS next quarter?
The consensus EPS estimate for Paysign for the quarter ending Dec 31, 2026 is $0.07 from 6 analysts, with estimates from $0.05 to $0.07.
How often does PAYS beat earnings estimates?
Paysign beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +14.97%.
PAYS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors